Navigation Links
Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
Date:11/3/2010

curities, available-for-sale

92,23354,500Prepaid expenses and other current assets

1,8501,529Total current assets

102,45593,687Property and equipment, net

9901,324Restricted cash

8811,290Other assets

299547Total assets

$
4,625$
96,848Liabilities and stockholders' equity Current liabilities:Accounts payable and accrued expenses

$
,885$
9,828Deferred revenue, current portion

3,51788Long-term debt, current portion

3,7416,384Total current liabilities

14,14316,300Deferred revenue, less current portion

47,190971Long-term debt, less current portion

-2,416Other long-term liabilities

4901,258Commitments and contingenciesStockholders’ equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at September 30, 2010 and December 31, 2009; noshares issued and outstanding at  September 30, 2010 and December 31, 2009

--Common stock, $.001 par value, 100,000,000 sharesauthorized at September 30, 2010 and December 31, 2009;47,556,739 and 47,215,479 shares issued and outstanding at September 30, 2010 and December 31, 2009, respectively

4847Additional paid-in capital

350,115342,599Accumulated other comprehensive income (loss)

4(6)Deficit accumulated during the development stage

(307,365)(266,737)Total stockholders’ equity

42,80275,903Total liabilities and stockholders’ equity

$
4,625$
96,848Orexigen Therapeutics, Inc.(a development stage company)Statements of Operations(In thousands, except per share amounts)(Unaudited) Period fromThree Months Ended Nine Months Ended September 12, 2002September 30, September 30, (Inception) to 2010200920102009September 30, 2010Revenues:Collaborative agreement $286$-$286$-$

460License revenue 22226666507Total revenues 3082235266967Operating expenses:Research and development 8,1869,59221,75338,579238,312General and administrative 6,
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
2. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
3. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
6. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
7. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
8. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
9. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
10. Cell Therapeutics Awarded $977,917 in Grants Under the Therapeutic Discovery Tax Credit Program
11. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)...  Boston Scientific has released the primary endpoint ... Failure (NECTAR-HF) clinical trial, the first and only ... (VNS) for the treatment of heart failure patients.  ... Cardiology and Director of the Clinical Investigation Center ... de la Recherche Medicale presented the results at ...
(Date:8/30/2014)... Mass. , Aug. 30, 2014   Royal ... of Affiniti, a new ultrasound system designed ... the demands of increasing patient volumes and cost pressures. ... Congress 2014 in Barcelona ... departments facing more patients with fewer resources deliver high ...
(Date:8/29/2014)... /PRNewswire-iReach/ -- Market Research Report on Global and ... professional and in-depth market survey on Global ... report firstly reviews the basic information of X-Ray ... technology. The report then explores global and China,s ... product specification, capacity, Production value, and market share ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
(Date:8/31/2014)... (PRWEB) August 31, 2014 Green ... harmful disc brake dust at the source while ... Problem: Millions of vehicles globally emit brake dust/debris ... in the friction materials (disc brake pads) are ... nations’ water systems. For example, copper impairs and ...
(Date:8/31/2014)... Priya Khan, Director of Research & Development at ... weight-loss supplements saying, “Consumers are understandably frustrated with ... propagated by unscrupulous companies about weight-loss products.” Even ... the subject. , NutriGold’s mission is to educate ... and to provide them with guidelines for choosing ...
(Date:8/31/2014)... August 31, 2014 To make it ... brand they can trust, NutriGold is shipping complimentary samples ... form has been set up to make taking advantage ... , According to Priya Khan, Director of Research and ... purchase one of our products, they are entrusting us ...
(Date:8/31/2014)... 2014 “Prohibition is our history,” ... our future: the present ~ that’s political.” , ... , new on the Bryan William Brickner Blog, ... system (CS) modulation and homeostasis - including one ... use. The Publius CS update includes: heteromerization ...
(Date:8/31/2014)... Top10BestSEOHosting.com has recently compared many professional web ... ), Bluehost and GoDaddy are the best hosting ... Top10BestSEOHosting.com says, “These companies have outperformed other competitors ... so that we call them the Best VPS ... get the best web hosting to enjoy the ...
Breaking Medicine News(10 mins):Health News:CBPModular Technology with Global Patent Coverage Solves Vehicle Wheel Brake Dust Problem 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 3Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Homeostasis: Publius’ Alcohol Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2Health News:Top10BestSEOHosting.com Announces The Best Hosting Suppliers In 2014: iPage, Bluehost and GoDaddy 2
... events , WEDNESDAY, May 5 (HealthDay News) -- A ... significantly cuts down on hospital drug errors, researchers from ... "We had the opportunity to design and implement a ... the hospital gets the right medication at the right ...
... those mental illnesses are still common, especially among women, survey ... report finds that older people have lower rates of mental ... the conditions remain common, especially in women. , Researchers led ... San Francisco analyzed a survey of 2,575 people aged 55 ...
... it may not help older men and women with sexual problems ... partner report greater happiness and those who talked with friends ... Journal of Gerontology: Social Sciences , shows that the way ... later years varies greatly and that there is not one solution ...
... ... Healthy CHOICES Act, and just days after the release of America’s first-ever ... and leaders from the fitness industry are gathering on Capitol Hill as ... will meet with Members of Congress to share their vision for a ...
... ... with online resources dedicated to the technical requirements associated with large format touch screens. ... particular makes this need an immediate one. See how they answered the call... ... (PRWEB) May 5, ...
... Research Institute (CRI) is participating in an international study ... and chronic lymphocytic leukemia. "This study is important ... to treat patients with leukemia or lymphoma," said Arthur ... Research Institute, and principal investigator for the Temple portion ...
Cached Medicine News:Health News:Bar Codes Cut Down on Hospital Medication Errors 2Health News:Bar Codes Cut Down on Hospital Medication Errors 3Health News:Friendship and confiding in spouse eases stress over sexual issues in older men 2Health News:Friendship and confiding in spouse eases stress over sexual issues in older men 3Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 2Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 3Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 4Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 5Health News:Horizon Display Demonstrates their Dedication to After-Sales Support with Enhanced Online Resources 2Health News:Horizon Display Demonstrates their Dedication to After-Sales Support with Enhanced Online Resources 3Health News:Scott & White Healthcare clinical trials target lymphoma, leukemia 2
A One Piece Support Garment - any length or size...
Body Suit w/Bra torso...
Male Compression Vest Binder...
Ideal for breast compression with adjustable hook and eye closure....
Medicine Products: